FDA Official Vinay Prasad Resigns Amid Controversy
TL;DR Summary
Vinay Prasad, a top FDA regulator, resigned amid political controversy over his handling of Sarepta's gene therapy for Duchenne muscular dystrophy, which included halting and then reinstating the treatment following safety concerns. His departure was seen as a positive development for the biotech sector, potentially leading to a more permissive regulatory environment.
- FDA’s Prasad Exits Following Political Backlash Over Sarepta Bloomberg.com
- Vinay Prasad, a powerful FDA official, departs after controversy over rare disease drug statnews.com
- FDA’s top vaccine official leaves post after less than four months The Guardian
- FDA vaccine chief leaving agency after less than 3 months AP News
- U.S. FDA's chief medical and science officer Prasad departs agency CNBC
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
92%
690 → 52 words
Want the full story? Read the original article
Read on Bloomberg.com